Pluristem CEO Zami Aberman to Speak on Panel at 9th Annual Stem Cell … – NASDAQ
|
Pluristem CEO Zami Aberman to Speak on Panel at 9th Annual Stem Cell …
NASDAQ Can allogeneic stem cell therapies save it? Traditional drug development means screening 10,000 compounds to get to 250 animal study candidates to get to 10 human study candidates to market 2 drugs. It takes so long that patents expire and costs can … |
